Australia #8118 (v.2)
Datos básicos
- Notificada en
-
G/MA/QR/N/AUS/5/Add.5 22/02/2023
- Validez de la versión
-
17/04/2022 -
actual
Versión activa actual v.2
- Miembro informante
- Australia
- En vigor desde
- Fecha de supresión
- Suprimida el
- Descripción general
-
Restriction on exports of COVID 19 rapid antigen test kits
- Fundamento jurídico nacional
-
Biosecurity (Human Biosecurity Emergency) (Human Coronavirus with Pandemic Potential) (COVID-19 Rapid Antigen Tests) Determination 2022.
The Determination is made under subsection 477(1) of the Biosecurity Act 2015 (Cth).
The measure was in place from 8 January 2022. The measure ceased on 17 April 2022.
- Mecanismo administrativo
-
The Determination prohibits the exports of COVID-19 rapid antigen test kits unless an exception under section 9 of the Determination applies. Section 9 outlines exceptions for both non-commercial and commercial purposes.
This is a temporary measure to ensure that COVID-19 rapid antigen test kits are reasonably and appropriately available to individuals who require a test, as part of Australia’s public health response to controlling the spread of COVID-19. - Entidades responsables
-
- Versión del SA
-
HS 2017
- Signatura de la OMC a que se hace referencia
Metadatos
- Justificaciones en el marco de la OMC
-
XI:2(a) - (a) Export prohibitions or restrictions temporarily applied to prevent or relieve critical shortages of foodstuffs or other products essential to the exporting contracting party;
GATT 1994 (GATT 1947 provisions)
Notificada como: GATT Art XI. 2(a) - Compromisos Internacionales (distintos de los asumidos en el marco de la OMC)
-
- Interlocutores afectados
- Interlocutores no afectados
Medidas
- Restricciones notificadas
- CP-X
Signatura |
---|
CP-X
|
Líneas arancelarias
3822
|
3822.19.09
|
COVID-19 rapid antigen test kit
|
|